Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancer
- 30 June 1995
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 109 (6) , 1205-1211
- https://doi.org/10.1016/s0022-5223(95)70204-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- p53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue baseThe American Journal of Surgery, 1992
- p53 function and dysfunctionCell, 1992
- p53, guardian of the genomeNature, 1992
- Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.Journal of Clinical Pathology, 1990
- A New International Staging System for Lung CancerChest, 1986
- p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.Molecular and Cellular Biology, 1985
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984